SEC Form 4 · accession 0001654954-17-005969
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven W Lefkowitz
Director
Period of report
Jun 25, 2017
Accepted (ET)
Jun 28, 2017 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value per shareF1 | holding | — | — | — | 59,963 | D | ||
| Common Stock, $0.001 par value per shareF2 | holding | — | — | — | 115,757 | I | Wade Capital Corporation Money Purchase Plan | |
| Common Stock, $0.001 par value per share | holding | — | — | — | 10,000 | I | Reporting Person's Wife |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock)F3 | $0.45 | Jun 25, 2017 | A | 75,000 | A | — | Jun 25, 2027 | Common Stock | 75,000 | 75,000 | D |
| Warrant (Right to Purchase Common Stock) | $0.90 | holding | — | — | — | Jan 8, 2015 | Jan 8, 2020 | Common Stock | 22,500 | 22,500 | D |
| Warrant (Right to Purchase Common Stock)F2 | $0.90 | holding | — | — | — | Jan 8, 2015 | Jan 8, 2020 | Common Stock | 15,000 | 15,000 | I |
Explanation of responses
- F1Includes 24,963 shares held by the reporting person for the benefit of his minor son.
- F2The reporting person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which he has voting and investment control).
- F3These options vest 1/3 on the date of grant, 1/3 on the first anniversary of the date of grant and 1/3 on the second anniversary of the date of grant.